These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22814143)

  • 41. [A case of Bartter's syndrome with chronic renal failure due to chronic interstitial nephritis].
    Maekawa K; Fujimoto T; Shiiki H; Kanauchi M; Fujii Y; Dohi K; Murata K; Takayanagi T
    Nihon Jinzo Gakkai Shi; 1998 May; 40(4):309-14. PubMed ID: 9654916
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Denosumab an option for patients with bone metastasis from breast cancer.
    Barton MK
    CA Cancer J Clin; 2011; 61(3):135-6. PubMed ID: 21532096
    [No Abstract]   [Full Text] [Related]  

  • 43. Zoledronic acid treatment at home: safety data from an observational prospective trial.
    Tassinari D; Poggi B; Nicoletti S; Fantini M; Tamburini E; Possenti C; Sartori S
    J Palliat Med; 2007 Apr; 10(2):352-8. PubMed ID: 17472506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral osteonecrosis associated with the use of zoledronic acid: first case of a patient with advanced pancreatic cancer and bone metastases.
    Smith A; Kressley A; Saif MW
    JOP; 2009 Mar; 10(2):212-4. PubMed ID: 19287122
    [No Abstract]   [Full Text] [Related]  

  • 45. Osteonecrosis of the jaw (ONJ) risk in breast cancer patients after zoledronic acid treatment.
    Fusco V; Loidoris A; Colella G; Vescovi P; Campisi G
    Breast; 2010 Oct; 19(5):432-3; author reply 433-4. PubMed ID: 20363135
    [No Abstract]   [Full Text] [Related]  

  • 46. A novel case of bisphosphonate-related osteonecrosis of the torus palatinus in a patient with metastatic breast cancer.
    Goldman ML; Denduluri N; Berman AW; Sausville R; Guadagnini JP; Kleiner DE; Brahim JS; Swain SM
    Oncology; 2006; 71(3-4):306-8. PubMed ID: 17657174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential effect of zoledronate therapy in heavy proteinuria.
    Gokden N; Zangari M; Elici F; Barlogie B; Kumar J
    Clin Nephrol; 2007 Apr; 67(4):263-5. PubMed ID: 17474565
    [No Abstract]   [Full Text] [Related]  

  • 48. A case of femoral diaphyseal fracture after long-term treatment with zoledronic acid.
    Ishizuna K; Ota D; Fukuuchi A; Teraoka M; Fujii A; Mori M; Nishi T
    Breast Cancer; 2015 Jan; 22(1):90-4. PubMed ID: 22009549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal safety of zoledronic acid administration beyond 24 months in breast cancer patients with bone metastases.
    Dincer M; Altundag K; Harputluoglu H; Aksoy S; Cengiz M; Gullu I
    Med Oncol; 2008; 25(3):356-9. PubMed ID: 18196480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Phase III clinical study of zoledronic acid in the treatment of pain induced by bone metastasis from solid tumor or multiple myeloma].
    Dong M; Feng FY; Zhang Y; Xie GR; Wang YJ; Liu JW; Song ST; Zhou QH; Ren J; Jiao SC; Li J; Wang XW; Chen Q; Wang ZH; Xu N; Feng JF
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):215-20. PubMed ID: 18756940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Inhibition of RANK ligand to treat bone metastases].
    Body JJ
    Bull Cancer; 2013 Nov; 100(11):1207-13. PubMed ID: 24158618
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serious ocular complications of zoledronate.
    Woo TC; Joseph DJ; Wilkinson R
    Clin Oncol (R Coll Radiol); 2006 Sep; 18(7):545-6. PubMed ID: 16969985
    [No Abstract]   [Full Text] [Related]  

  • 53. Acute renal failure secondary to interstitial acute nephritis and Fanconi syndrome for metamizole and gemfibrozil.
    Martín-Navarro JA; Petkov-Stoyanov V; Gutiérrez-Sánchez MJ; Pedraza-Cezón L
    Nefrologia; 2016; 36(3):321-3. PubMed ID: 26306948
    [No Abstract]   [Full Text] [Related]  

  • 54. [A successful case treated with S-1 and zoledronic acid for multiple bone metastasis of breast cancer].
    Nakamoto Y; Kayata Y; Kikawa Y; Ogata M; Yamamoto M
    Gan To Kagaku Ryoho; 2011 May; 38(5):811-3. PubMed ID: 21566443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tubulointerstitial nephritis and Fanconi syndrome in primary biliary cirrhosis.
    Lino M; Binaut R; Noël LH; Patey N; Rustin P; Daniel L; Serpaggi J; Varaut A; Vanhille P; Knebelmann B; Grünfeld JP; Fakhouri F
    Am J Kidney Dis; 2005 Sep; 46(3):e41-6. PubMed ID: 16129198
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Case of Sjögren's Syndrome Complicated with Interstitial Nephritis and Delayed Onset Autoimmune Hepatitis.
    Yamada T; Fukui M; Kashiwagi T; Arai T; Itokawa N; Atsukawa M; Shimizu A; Tsuruoka S
    J Nippon Med Sch; 2018; 85(2):117-123. PubMed ID: 29731495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute Bilateral Anterior Uveitis after a Single Intravenous Infusion of Zoledronic Acid in Metastatic Breast Cancer.
    Jun JH
    Korean J Ophthalmol; 2017 Aug; 31(4):368-369. PubMed ID: 28682020
    [No Abstract]   [Full Text] [Related]  

  • 58. Re: Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases.
    Tu SM; Chen AH
    Can J Urol; 2012 Jun; 19(3):6268. PubMed ID: 22704311
    [No Abstract]   [Full Text] [Related]  

  • 59. The clinical response on bone metastasis from breast and lung cancer during treatment with zoledronic acid is inversely correlated to skeletal related events (SRE).
    Facchini G; Caraglia M; Santini D; Nasti G; Ottaiano A; Striano S; Maiolino P; Ruberto M; Fiore F; Tonini G; Budillon A; Iaffaioli RV; Zeppetella GL
    J Exp Clin Cancer Res; 2007 Sep; 26(3):307-12. PubMed ID: 17987788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effects of zoledronic acid in the treatment of breast cancer].
    Chen J; Liu ZY; Zhao LJ
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):318-9. PubMed ID: 21575510
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.